207 related articles for article (PubMed ID: 28641295)
1. Diagnosis, Assessment, and Therapeutic Strategy for Colorectal Mixed Adenoneuroendocrine Carcinoma.
Tanaka T; Kaneko M; Nozawa H; Emoto S; Murono K; Otani K; Sasaki K; Nishikawa T; Kiyomatsu T; Hata K; Morikawa T; Kawai K; Watanabe T
Neuroendocrinology; 2017; 105(4):426-434. PubMed ID: 28641295
[TBL] [Abstract][Full Text] [Related]
2. Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report.
Semrau S; Agaimy A; Pavel M; Lubgan D; Schmidt D; Cavallaro A; Golcher H; Grützmann R; Fietkau R
J Med Case Rep; 2019 Mar; 13(1):82. PubMed ID: 30902067
[TBL] [Abstract][Full Text] [Related]
3. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation.
Komatsubara T; Koinuma K; Miyakura Y; Horie H; Morimoto M; Ito H; Lefor AK; Sata N; Fukushima N
Clin J Gastroenterol; 2016 Feb; 9(1):1-6. PubMed ID: 26699873
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Prognostic Evaluations of Mixed Adenoneuroendocrine Carcinoma of the Colon and Rectum: A Case-Matched Study.
Watanabe J; Suwa Y; Ota M; Ishibe A; Masui H; Nagahori K; Tsuura Y; Endo I
Dis Colon Rectum; 2016 Dec; 59(12):1160-1167. PubMed ID: 27824701
[TBL] [Abstract][Full Text] [Related]
5. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature.
Zhang L; DeMay RM
Diagn Cytopathol; 2014 Dec; 42(12):1075-84. PubMed ID: 24554593
[TBL] [Abstract][Full Text] [Related]
6. [Mixed adenoneuroendocrine carcinoma (MANEC) of the gastrointestinal tract].
Šefr R; Němec L; Fabian P; Fiala L
Rozhl Chir; 2017; 96(1):41-44. PubMed ID: 28325058
[TBL] [Abstract][Full Text] [Related]
7. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis, treatment and prognosis of neuroendocrine carcinoma of the colorectum].
Zhang YC; Zhuang J; Han GS; Wang JB
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Dec; 14(12):955-7. PubMed ID: 22205457
[TBL] [Abstract][Full Text] [Related]
9. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
Acosta AM; Wiley EL
Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
[TBL] [Abstract][Full Text] [Related]
10. Mixed adenoneuroendocrine carcinoma originating from the appendix and colorectum: a comparative analysis of a large population-based database.
Zhao B; Wang J; Ye H; Cheng X; Meng K; Yang T
Tech Coloproctol; 2023 Nov; 27(11):1017-1024. PubMed ID: 36995458
[TBL] [Abstract][Full Text] [Related]
11. A Rare Type of Colorectal Cancer: Mixed Adeno-Neuroendocrine Carcinoma (MANEC).
Cherbanyk F; Gassend JL; Dimitrief M; Andrejevic-Blant S; Martinet O; Pezzetta E
Chirurgia (Bucur); 2017; 112(2):152-156. PubMed ID: 28463674
[TBL] [Abstract][Full Text] [Related]
12. Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
Dulskas A; Pilvelis A
Eur J Surg Oncol; 2020 Jan; 46(1):105-107. PubMed ID: 31444026
[TBL] [Abstract][Full Text] [Related]
13. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
[TBL] [Abstract][Full Text] [Related]
14. Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.
Tränkenschuh W; Biesdorf AS; Papadimas N; Samara S; Hefty R; Stahl PR
Int J Surg Pathol; 2019 Sep; 27(6):684-692. PubMed ID: 30955388
[TBL] [Abstract][Full Text] [Related]
15. Mixed Adenoneuroendocrine Carcinoma of the Gallbladder.
Lin YX; Jia QB; Fu YY; Cheng NS
J Gastrointest Surg; 2018 Aug; 22(8):1452-1454. PubMed ID: 29313288
[TBL] [Abstract][Full Text] [Related]
16. Management of MANEC of the colon and rectum: A comprehensive review of the literature.
Paspala A; Machairas N; Prodromidou A; Spartalis E; Ioannidis A; Kostakis ID; Papaconstantinou D; Nikiteas N
Mol Clin Oncol; 2018 Aug; 9(2):219-222. PubMed ID: 30101026
[TBL] [Abstract][Full Text] [Related]
17. Massive Mixed Adenoneuroendocrine Carcinoma: A Case Report.
Millet C; Farokhian A; Mekheal N; Singh B; Baddoura W
Cureus; 2021 Jun; 13(6):e15928. PubMed ID: 34258127
[TBL] [Abstract][Full Text] [Related]
18. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
19. Mixed adenoneuroendocrine carcinoma of the colon and rectum.
Qiu S; Pellino G; Warren OJ; Mills S; Goldin R; Kontovounisios C; Tekkis PP
Acta Chir Belg; 2018 Oct; 118(5):273-277. PubMed ID: 29911510
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Carcinoma of Gall Bladder: A Series of 19 Cases with Review of Literature.
Kamboj M; Gandhi JS; Gupta G; Sharma A; Pasricha S; Mehta A; Chandragouda D; Sinha R
J Gastrointest Cancer; 2015 Dec; 46(4):356-64. PubMed ID: 26208508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
